Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)

Exclusion Criteria

• •Presence or history of venous or arterial thrombotic/thromboembolic events
• •or cerebrovascular accident
• •Presence or history of prodromi of a thrombosis
• •History of migraine with focal neurological symptoms
• •Diabetes mellitus with vascular involvement
• •Presence of a severe or multiple risk factor(s) for venous or arterial
• •thrombosis
• •Severe hypertension
• •Severe dyslipoproteinemia
• •Presence or history of pancreatitis associated with severe
• •hypertriglyceridemia
• •Presence or history of severe hepatic disease
• •Undiagnosed vaginal bleeding
• •Known or suspected pregnancy
• •Currently breastfeeding or breastfeeding within 2 months of starting
• •trial medication
• •\- Investigational drug use or participation in another clinical trial within
• •2 months of signing Informed Consent Form for current trial